WPI 2281 (Zolpidem Tartrate Extended-Release 6.25 mg)
Pill with imprint WPI 2281 is Green, Round and has been identified as Zolpidem Tartrate Extended-Release 6.25 mg. It is supplied by Watson Laboratories, Inc.
Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2281

Zolpidem Tartrate Extended-Release
- Imprint
- WPI 2281
- Strength
- 6.25 mg
- Color
- Green
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-2281
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
FD&C Blue No. 1,
FD&C Blue No. 2,
hydroxypropyl cellulose,
hypromelloses,
ferrosoferric oxide,
ferric oxide yellow,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polyethylene glycol,
propylene glycol,
sodium bicarbonate,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
polysorbate 80
Note: Inactive ingredients may vary.
More about zolpidem
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (993)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
Patient resources
- Drug Information
- Zolpidem (Advanced Reading)
- Zolpidem Oral, Oromucosal (Advanced Reading)
- Zolpidem Extended-Release Tablets
- Zolpidem Sublingual Tablets (Intermezzo)
Other brands
Ambien, Ambien CR, Zolpimist, Edluar, Intermezzo
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.